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Introduction 
Bone is unusual among structural materials as it is alive and capable of self-repair.  
It is classed as a connective tissue, as it is composed of cells and their products which 
 8 
form an organic matrix, which is then mineralised.   There are four principal cell types, 
three of which share a common lineage.  These include the osteoblasts which actively 
secrete the organic matrix of collagen and other proteins.  When bone formation has 
ceased, some osteoblasts become quiescent and flattened on the bone surface and are 
termed bone lining cells.  In 10-20% of cases, osteoblasts wall themselves off in spaces or 
lacunae and differentiate into osteocytes.  Osteocytes are less active, but communicate 
with each other via processes which run along canals between lacunae.  This network of 
osteocytes within the matrix is thought to act as a mechanosensor (1, 2).  The fourth cell 
type, the osteoclast, has a common origin with white blood cells.  It is large, with up to 10 
nuclei, and can secrete acid to demineralise bone and enzymes to digest the organic 
matrix.  
Bone may be classified on the basis of density into compact/cortical (> 0.7 kg/m3) 
or trabecular/cancellous (< 0.7 kg/m3) (3).  Bones grow in two ways; by endochondral 
and by intramembraneous ossification.  In the former, a cartilagenous model or anlagen is 
formed which becomes calcified and is then resorbed by osteoclasts.  In its place, 
osteoblasts lay down organic matrix, or osteoid, which is then mineralised to form bone.  
Endochondral ossification is responsible for growth in length of limb bones.  In 
intramembranous ossification, there is no cartilagenous anlagen.  Osteoblasts lay down 
osteoid within well vascularised connective tissue and this is then mineralised; this causes 
limb bones to grow in width. Growth accounts for approximately 95% of bone mass (4).  
Bones are shaped by a process called modelling, where activation is followed by 
osteoblast activity (bone formation) at some sites and osteoclast avtivity (bone resorption) 
at others .  In contrast, bone remodelling is the bone replacement mechanism of the 
skeleton and mediates the effects of all agents - hormonal, nutritional or mechanical - that 
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act on it.    Bone remodelling is carried out by temporary anatomic structures termed 
basic multicellular units or BMUs (5).  In compact bone, each comprises a cutting cone of 
osteoclasts in front, which resorb bone, with a closing cone of osteoblasts, which lay 
down new osteoid, following behind.  Parfitt et al (6) have described a similar sequence 
in trabecular bone, where a trench is dug by osteoclasts and filled in by osteoblasts.  In 
both cases, activation is followed by resorption and formation, an A-R-F sequence, with 
characteristic temporal and spatial relationships between the osteoclasts and osteoblasts.  
Given the large number of local hormones and growth factors involved in bone 
turnover, the influences on their actions by systemic hormones, and the complexity of 
their interactions, it is not surprising that the remodelling process is incompletely 
understood. Lanyon (7) has argued that functional strain is the controlling influence on 
bone remodelling, acting via prostaglandin E2.  In contrast, Cowin et al (1) argue that 
strain potentials, generated by the hydraulic drag and electrokinetic contribution of bone 
fluid passing along the canalicular network and through the osteocytic membrane, couple 
mechanical loading and cellular response.  However, a consistent finding has been that 
the activating stimulus must be repetitive, i.e. cyclic, - hence bone remodelling can be 
viewed as a fatigue phenomenon. This may range from repetitive elastic deformation, 
where the bone is strained but returns to its original form, to plastic deformation where 
the applied load causes the material to yield resulting in permanent deformation or 
damage.  Tschantz and Rutishauser (8) provided the first experimental evidence that the 
damage caused by repetitive stresses can stimulate bone adaptation.  Subsequent 
theoretical arguments (9 – 15) and experimental data (16 – 21) have supported this link 
between fatigue microdamage and remodelling.  
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If we accept the paradigm that microdamage stimulates remodelling, then equally 
we might say that remodelling repairs microdamage.  Schaffler et al (22, 23) have shown 
the similarities between fatigue damage generated in vitro and such in vivo microdamage.  
The generation of fatigue microdamage is proportional to the load, the number of cycles 
and temperature.  Should such microdamage be permitted to accumulate, the strength of 
the bone would be reduced, making it more susceptible to fracture (24).  There are two 
mechanisms by which such damage accumulation can occur:  
(1)  the generation of damage at a rate above which the remodelling / repair 
 mechanism can remove it  - excess damage  
(2)  a normal rate of damage generation coupled to a defective remodelling /  repair 
mechanism - deficient repair.   
It has been hypothesised that, in vivo, excessive damage results in "stress fractures" and 
deficient repair leads to "fragility fractures". 
Stress fractures 
A stress fracture is a partial or complete fracture in normal bone caused by 
repetitive stresses rather than by a specific traumatic episode. In 1855 Breithaupt, a 
Prussian Army physician, described the syndrome of a painful, swollen foot associated 
with marching (25).  They are caused by the application of an abnormal muscular stress 
or torque to a bone which has normal elastic resistance and are most commonly 
associated with a new, strenuous and repetitive activity (26).  This is due to the ability of 
muscles to adapt more quickly than bones to the new activity, leading to a mechanical 
imbalance.  The increased muscle force acting on the relatively weaker bone causes 
deformation, microdamage accumulation and fracture (26, 27).  They occur in over 40% 
of certain elite units of the military (28) and in 3.7% of varsity athletes (29). Stress 
 11 
fractures of the metatarsals and calcaneus are common in runners (30, 31); of the spinal 
pars interarticularis in ballet dancers and gymnasts (32) and of the hook of the hamate in 
golfers (33).  Fatigue fractures within trabecular bone have been found clinically in the 
proximal femur, in the calcaneus (including Michael Jordan's) and in the proximal tibia 
(34). In horses, humeral stress fractures usually require the animal to be destroyed.  
Stover et al (35) reported 21 such fractures during an 18 month period at one California 
racetrack.  
Fortunately, the patient becomes symptomatic relatively early in the course of this 
condition with pain occurring at the time of accelerated remodelling.  Simply ceasing the 
activity is usually an effective treatment at this point.   The relative youth and the onset of 
symptoms at an early and easily treatable stage in stress fracture patients are in marked 
contrast with those suffering from fragility fractures. 
Fragility fractures 
The term "fragility fractures" describes fractures that occur in response to the 
minor traumas that are part of everyday life (36).  Microdamage accumulation leads to 
diminished bone quality and, together with loss of bone quantity, results in weakened 
bones which may break following minor falls. Their incidence is greatest at sites where 
trabecular bone is the dominant form and has increased in the western world over the past 
30 years (37).  In the United States, 280,000 hip fractures (38), 700,000 vertebral, 
250,000 Colles' fractures and 300,000 fractures at other limb sites (39) occur each year at 
a fiscal cost of $10 billion (40).  Following hip fracture, there is a 10-20% mortality over 
the subsequent six months, 50% of patients will be unable to walk without assistance and 
25% will require long-term domiciliary care (39). Demographic trends indicate that the 
 12 
number of hip fractures worldwide could increase from an estimated 1.7 million in 1990 
to 6.3 million in 2050 (41).   
Objectives 
Microdamage, therefore, is an activator of remodelling and may have important 
clinical sequelae.  But what is it, how can we detect it, how can we monitor its growth 
and how can we use these data to predict, and perhaps prevent, tissue failure?   
 
Material and Method 
Detection - Human rib 
Basic fuchsin 
Human rib was chosen as it is moved by the respiratory muscles approximately 12 times 
per minute during life and has been shown to contain naturally occurring fatigue 
microdamage (42 - 44).  Ten ribs were excised from cadavers (age 49-92 years), mounted 
in a diamond saw (Struers Minitom) and 0.5 cm bone blocks cut in sequence 
commencing distal to the tubercle.  The first block was stained in basic fuchsin (44) and 
embedded in methylmethacrylate polymer (MMA) to facilitate serial sectioning. The 
polymer consisted of a monomer (methylmethacrylate), a softener (dibutyl phthalate) 
which prevented the finished polymer being too brittle, and a catalyst (benzoyl peroxide).  
The blocks were infiltrated with the MMA solution in a vacuum desiccator (50 mm Hg) 
at room temperature over a period of 3 days.  They were then placed in an oven at 55°C 
for 4 days to polymerize and harden. The embedded blocks were mounted on a LKB 
sledge macrotome and 10 µm serial sections of bone were cut longitudinally through a 
depth of 250 µm.   These sections were soaked in 90% ethanol to soften the polymer and 
any folds or creases were unfurled and flattened using a brush and forceps.  The sections 
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were then mounted on glass slides with DPX mounting medium under a coverslip.   
Fuchsin-stained cracks were identified using the fluorescence-aided method (45).  
Microcrack images were transferred to a PC using a CCD camera, reference points were 
noted on each slice and, using Surfdriver TM computer software, the serial slices were 
reconstructed into three dimensional images of each individual microcrack.  
Measurements of crack length in the longitudinal direction, parallel to osteons, and of 
crack width were made from the reconstructed images using image analysis software 
(Scion ImageTM). 
Fluorescent dyes 
The remaining blocks from each rib were randomly assigned for bulk staining in one of 
four fluorescent dyes: calcein, calcein blue, alizarin and xylenol orange (46).  Blocks 
were then secured in a diamond saw (Struers Minitom), 250 µm transverse sections cut, 
handground to between 100 and 150 µm and mounted.  Microcracks were identified using 
epifluorescence microscopy and the site and number in each section recorded.  
Microcrack images were transferred to a PC via the CCD camera and the length of each 
microcrack measured (Scion ImageTM).  Finally, the area of each section was determined 
by transferring the image of each section to the PC using a CCTV video camera and 
measuring it using the same analysis software. 
 
Monitoring Microcrack Growth - Bovine tibia 
Scratch tests 
Fresh bovine tibiae were obtained from a meat wholesaler, soft tissue was removed and 
the bones stored at -20oC until required.  Samples of cortical bone were removed from the 
mid-diaphysis of the tibiae and machined into beam-shaped specimens using a band saw.  
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These were then finely polished using emery paper. Using a compass point, a 5mm 
straight line was scratched on the upper surface of the bone beams.  Each specimen was 
immersed in a vial containing a 5 x 10-4M aqueous solution of a fluorescent dye (46) and 
placed in a vacuum desiccator for 4 hours.  The specimen was washed in de-ionised 
water, a second 5mm line scratched parallel to the first and the specimen immersed in a 
vial containing a 5 x 10-4M aqueous solution of a second fluorescent and placed in the 
vacuum desiccator for 4 hours.  This protocol was repeated using two, three and four dye 
sequences of calcein, calcein blue, alizarin, xylenol orange and oxytetracycline. 
Fatigue tests 
Samples of cortical bone were removed from the mid-diaphysis of 15 bovine tibiae.  
Specimens were machined into a typical, waisted, "dog-bone" type of circular cross 
section.  Fatigue testing was carried out using an Instron 8501 servo-hydraulic testing 
machine, set in load control to apply an axial compressive force to the specimens, and 20 
tests were carried out, with five specimens initially being used to establish a test protocol.  
All specimens were tested at a frequency of 3 Hz, cycling between 11 and a 111 MPa to 
give a stress range value of 100 MPa and a stress ratio of 0.1.  A constant stress range 
was used in order to study the number of cycles to failure (Nf).  Before testing, each 
specimen was placed overnight in a vial of alizarin, in a vacuum desiccator, to label pre-
existing damage.  By sampling, at various intervals during the test, it was possible to look 
at the deformation that occurred during the progression of a test and relate it to loss in 
stiffness. Data were displayed on the computer screen and so it was possible to stop the 
test at intervals to apply fluorochromes to label microdamage initiation and accumulation 
during the test.   
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Results and Discussion 
Human rib: basic fuchsin 
Nine microcracks, each from a different rib, were reconstructed from serial sections and 
all were oriented along the long axis of the ribs, parallel to osteons.  They were 
approximately elliptical in shape, with mean length 404 µm (SD:145), width 97 µm (SD: 
37) and thickness 9 µm (SD: 3).  These are consistent with published data on the 
dimensions of in vivo microcracks (Table 1).  The length:width ratio was found to be 4.6 
suggesting that crack growth is relatively easy in the longitudinal, but difficult in the 
transverse, direction.  This is characteristic of a transversely anisotropic material and is 
consistent with a previous observation (12) and theoretical prediction (47). Taylor and 
Lee (47) showed that the methods of stereology could be applied to previous published 
data on crack lengths measured from 2D sections taken transversely and, in one case, 
longitudinally. The mean and standard deviation of these length measurements can be 
used to predict the 3D crack shape.  It was found that the data were consistent with cracks 
of width 66-113µm and aspect ratio between 4:1 and 5:1. The 3D cracks imaged in this 
paper are thus correctly predicted. The uniformity in measured crack dimensions (Table 
1) suggests that a balance is achieved between crack growth and repair/remodelling 
which removes damaged bone.  This may serve to keep cracks below a critical length and 
so prevent propagation to failure. 
Basic fuchsin does not bind metal ions such as calcium (48), but binds proteins such as 
collagen (49) which comprises 30% of bone by weight.  It has been used in sequence with 
toluidine blue but differentiation of pre-existing microcracks, stained with both dyes, and 
test-induced microcracks stained with fuchsin is difficult (50). 
Human rib: fluorochrome dyes 
 16 
All four aqueous fluorescent dyes, calcein, calcein blue, alizarin and xylenol orange 
labelled the cut ends of the bone block, resorption cavities and mineralising osteoid on 
bone surfaces. They also labelled microcracks (Fig. 1) which were identified using 
standardised criteria (46).  Microcrack density ranged from 13 – 18/ cm2 and mean width 
(length in transverse section) from 62 – 70 µm.  There was no significant difference in 
microcrack density, width or location between the four stains and these are consistent 
with data from fuchsin-stained rib sections (45, 46).   
Each dye has two adjacent donor sites capable of forming a strong ring or chelate with 
calcium ions.  Their ability to bind exposed calcium in damaged bone, osteoid and 
resorption cavities has been observed before (51, 52) and calcein was reported to label 
microcracks when given intravenously to horses (53).  This labelling pattern suggests that 
calcium ions line the walls of microcracks.  This is consistent with a bone matrix where 
hydroxyapatite crystals, Ca10(PO4)6(OH)2, develop in length along the collagen long 
axes and in width along channels within the collagen sheets (54).  In  such a two-phase 
structure, a microcrack would most likely be a break or fissure in the hydroxyapatite 
matrix, exposing new surfaces.  This would involve the cleaving of bonds between 
constituent atoms leaving charged ions exposed on the surfaces of the microcrack  - 55% 
of the ions present are Ca2+.  The ability of chelating agents to label microcracks thus 
gives indirect evidence of their nature and, because of their site-specific binding, the 
possibility of using them in sequence to label microcrack growth.  This principle was 
tested using a surface scratch model. 
Bovine tibia: scratch tests 
The surface scratches were clearly labelled with all five fluorescent dyes.  Alizarin and 
calcein, alizarin and xylenol orange, xylenol and calcein, and alizarin and calcein blue 
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were found to be successful two dye sequences, as there was minimal substitution of the 
first dye by the second on the measured scratches.  The optimal dye sequence for three 
agents was alizarin, xylenol and calcein.  As all dyes were at the same molar 
concentration, the sequence is determined by their affinity for exposed Ca2+ ions, the 
chelating agent with greatest affinity being applied first.  Problems were encountered 
with the use of calcein blue and oxytetracycline, as oxytetracycline was found to 
substitute calcein blue.  A reversal of this sequence was performed, but calcein blue was 
then found to substitute oxytetracyline.  Oxytetracycline was also found to substitute 
calcein and xylenol to a small degree and so the concentration of oxytetracycline was 
reduced to 5 x 10-5M.  As substitution still occurred, oxytetracycline was eliminated from 
the study. The optimal four agent sequence was  alizarin, xylenol orange,  calcein and 
calcein blue (Fig. 2).  This sequence of site-specific chelating agents offers the 
opportunity to differentiate pre-existing microdamage from that introduced by fatigue 
testing, using a two-dye sequences, and to label microcrack growth using a longer 
sequence of dyes given at intervals during testing. 
Bovine tibiae: fatigue tests 
The average fatigue life of the specimens in this study was 35,000 cycles to failure which 
corresponds to a strength at 100,000 cycles of 91.6MPa. This compares favourably with 
the value of 92.3MPa predicted by Taylor's model (55). A range of several orders of 
magnitude was found (514 – 140,000 cycles), but this is similar other studies (56, 57).  
This suggests that the scatter is not due to inadequacies in the testing technique, but to the 
bone material itself.  Although the specimens tested were of exactly the same dimensions 
and all came from the mid-diaphysis of bovine tibiae, factors such as orientation of the 
bone lamellae, porosity, degree of mineralisation may explain the large variation in 
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fatigue life from specimen to specimen. These initial experimental results appear to have 
validated the accuracy of the mathematical model as it appears to be able to predict the 
strength of bovine bone in compression by combining the effects of specimen size, 
temperature and loading frequency.   Figure 3 shows a microcrack, labelled sequentially 
with two fluorescent chelating agents, indicating crack growth during fatigue testing. 
Failure prediction 
This information on crack density, length and aspect ratio can be used to calculate stress 
intensity (K) values for these cracks. Taylor (55, 58) has developed a theoretical model to 
predict crack growth rates, numbers of cycles to failure and the rate of decrease of elastic 
stiffness for samples of bone containing a known density of microcracks. Predictions 
from this model have compared favourably with test data, but assumptions were required 
about the crack growth laws for this material, especially in the short-crack regime. These 
cracks spend most of their lives in the regime which, for engineering materials, is referred 
to as 'microstructurally short', since they interact significantly with features such as 
osteon boundaries whose separation is of the order of 100 µm.  Further work must be 
done to measure the growth rates of these cracks, but the technique described above has 
the potential for providing this data, which will be invaluable for our theoretical model. 
Conclusions 
1) Microcracks are normally present in bone and are elliptical in shape, approximately 
400 µm long and 100 µm wide.  They are found predominantly in interstitial bone and 
run parallel to Haversian systems and the long axis of the bone.   
2) They can be labelled using chelating agents, this suggests that microcracks are 
discontinuities in the hydroxyapatite matrix.   
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3) A pair of chelating agents has been used to differentiate pre-existing from test-
induced microdamage, and their fluorescence properties aided detection. 
4) Further work, using a longer sequence of chelating agents, is required to label 
microcrack growth during fatigue testing and to relate it to changes in material 
properties.  A knowledge of crack growth rates is required to utilise theoretical 
models to predict fatigue failure in bone.  However, to apply such models to living 
bones and predict stress or fragility fractures in patients, a non-invasive method of 
detecting labelled microcracks will be required. 
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Table and Figure Legends 
 
Table 1  Dimensions of microcracks stained with basic fuchsin . 
 
Figure 1.  Microcracks in transverse sections of human rib  labelled with (a) calcein blue 
(UV epifluorescence, λ =  365 nm) and (b) xylenol orange (green epifluorescence, λ =  
546 nm; Bar = 50 µm). 
 
Figure 2  Four agent scratch sequence of alizarin, xylenol orange, calcein and calcein 
blue. ( UV epifluorescence, λ =  365 nm; Bar = 100 µm). 
 
Figure 3.  Microcrack growth during fatigue testing of bovine bone.  Surface and pre-
existing microcrack labelled with alizarin (red) and test-induced crack growth labelled 
with calcein (green). ( UV epifluorescence, λ =  365 nm;  Bar = 50 µm). 
 
 
 
 
Table 1   Dimensions of microcracks stained with basic fuchsin . 
 
Source   Length (SD) µm  Width (SD) µm 
Bovine femur  N/A     80 (13) 
Equine metacarpal   N/A    88 (54) 
Human rib  296 (257)   88 (38) 
Human rib*  404 (145)   97 (37) 
Canine radius  N/A    58 (3) 
Ovine radius** N/A    52 (13)  
N/A: not available 
Data from Burr & Martin (12) except: * current study, **  Lee et al (18).   
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(b) 
 
Figure 1.  Microcracks in transverse sections of human rib  labelled with (a) calcein blue 
(UV epifluorescence, λ =  365 nm) and (b) xylenol orange (green epifluorescence, λ =  
546 nm; Bar = 50 µm). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
   
 
Figure 2  Four agent scratch sequence of alizarin, xylenol orange, calcein and calcein 
blue. ( UV epifluorescence, λ =  365 nm; Bar = 100 µm). 
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Figure 3.  Microcrack growth during fatigue testing of bovine bone.  Surface and pre-
existing microcrack labelled with alizarin (red) and test-induced crack growth labelled 
with calcein (green). ( UV epifluorescence, λ =  365 nm;  Bar = 50 µm). 
 
 
 
 
 
 
 
 
 
 
 
 
 
